INSR and breast cancer: The possible mechanism is that the overexpression of insulin growth factor receptor-1R (IGF-1R) or insulin receptor (IR) leads to mitotic signaling and increases the activation of phosphoinositide-3-kinase (PI3)-Akt-mTOR signaling pathway (68), which mediates the development of BC and EC.